Europe COPD & Asthma Devices Market (2016-2022)

October 2016 | 134 pages | ID: E16C5227CD8EN
KBV Research

Abstracts

Growing aging population coupled with increasing automotive and industrial exhaust gases have remained the key drivers for the Europe asthma and COPD market. Degrading air quality near the industrial areas has led to the increased incidence of asthma. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions. However, the unknown etiology of asthma and COPD in medical industry may hamper the market growth in the next six years. Upcoming treatment methodologies such as once-a-day combination products and monoclonal antibodies have created new opportunities for the market growth. Additionally, pharmaceutical companies have been developing new bio-based medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for asthma & COPD market over the next decade.

The report highlights the adoption of COPD & Asthma Devices in Europe. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The Countries included in the report are Russia, Germany, UK, France, Spain, Italy and Rest of Europe.

Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.

Contents

CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Europe COPD & Asthma Devices, By Product Type
  1.4.2 Europe COPD & Asthma Devices Market, By Country
1.5 Research Methodology

CHAPTER 2. EUROPE COPD AND ASTHMA DEVICES MARKET OVERVIEW

2.1 Introduction
2.2 Key Influencing Factors
2.3 Europe COPD & Asthma Device Market

CHAPTER 3. EUROPE COPD AND ASTHMA DEVICE MARKET - BY PRODUCT TYPE

3.1 Europe COPD & Asthma Inhaler Market
  3.1.1 Europe COPD & Asthma Inhaler Market - By Product Type
      3.1.1.1.1 Europe COPD & Asthma Dry Powder Inhalers (DPIs) Market
      3.1.1.1.2 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
      3.1.1.1.3 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
    3.1.1.2 Europe COPD & Asthma Inhaler Market
      3.1.1.2.1 Europe COPD & Asthma Inhaler Market - By Country
      3.1.1.2.2 Europe COPD & Asthma Dry Powder Inhalers (DPIs) Market
      3.1.1.2.3 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
      3.1.1.2.4 Europe COPD & Asthma Soft Mist Inhalers (SMIs) Market
      3.1.1.2.5 Europe COPD & Asthma Pneumatic Nebulizer Market
      3.1.1.2.6 Europe COPD & Asthma Ultrasonic Nebulizer Market - By Country
      3.1.1.2.7 Europe COPD & Asthma Mesh Nebulizer Market - By Country
    3.1.1.3 Europe COPD & Asthma Nebulizer Market - By Product Type
      3.1.1.3.1 Europe COPD & Asthma Nebulizer Market - By Country
      3.1.1.3.2 Europe COPD & Asthma Pneumatic Nebulizer Market
      3.1.1.3.3 Europe COPD & Asthma Ultrasonic Nebulizer Market
      3.1.1.3.4 Europe COPD & Asthma Mesh Nebulizer Market

CHAPTER 4. EUROPE COPD & ASTHMA DEVICES MARKET - BY COUNTRY

  4.1.1 Russia COPD and Asthma Devices Market
    4.1.1.1 Russia COPD and Asthma Devices Market - By Product Type
      4.1.1.1.1 Russia COPD and Asthma Inhalers Market - By Product Type
      4.1.1.1.2 Russia COPD and Asthma Nebulizers Market
  4.1.2 Germany COPD and Asthma Devices Market
    4.1.2.1 Germany COPD and Asthma Devices Market - By Product Type
      4.1.2.1.1 Germany COPD and Asthma Inhalers Market
      4.1.2.1.2 Germany COPD and Asthma Nebulizers Market
  4.1.3 UK COPD and Asthma Devices Market
    4.1.3.1 UK COPD and Asthma Devices Market
      4.1.3.1.1 UK COPD and Asthma Inhalers Market
      4.1.3.1.2 UK COPD and Asthma Nebulizers Market
  4.1.4 France COPD and Asthma Devices Market
    4.1.4.1 France COPD and Asthma Devices Market - By Product Type
      4.1.4.1.1 France COPD and Asthma Inhalers Market
      4.1.4.1.2 France COPD and Asthma Nebulizers Market
  4.1.5 Spain COPD and Asthma Devices Market
    4.1.5.1 Spain COPD and Asthma Devices Market - By Product Type
      4.1.5.1.1 Spain COPD and Asthma Inhalers Market
      4.1.5.1.2 Spain COPD and Asthma Nebulizers Market
  4.1.6 Italy COPD and Asthma Devices Market
    4.1.6.1 Italy COPD and Asthma Devices Market - By Product Type
      4.1.6.1.1 Italy COPD and Asthma Inhalers Market
      4.1.6.1.2 Italy COPD and Asthma Nebulizers Market
  4.1.7 Rest of Europe COPD and Asthma Devices Market
    4.1.7.1 Rest of Europe COPD and Asthma Devices Market - By Product Type
      4.1.7.1.1 Rest of Europe COPD and Asthma Inhalers Market
      4.1.7.1.2 Rest of Europe COPD and Asthma Nebulizers Market

CHAPTER 5. COMPANY PROFILES

5.1 Glaxosmithcline PLC
  5.1.1 Company Overview
  5.1.2 Financial Analysis
  5.1.3 Segmental Analysis
  5.1.4 Research & Development
5.2 Novartis International AG
  5.2.1 Company Overview
  5.2.2 Financial Analysis
  5.2.3 Segmental Analysis
  5.2.4 Research & Development
5.3 Merck & Co., Inc.
  5.3.1 Company Overview
  5.3.2 Financial Analysis
  5.3.3 Segmental Analysis
  5.3.4 Research & Development
5.4 AstraZeneca Plc
  5.4.1 Company Overview
  5.4.2 Financial Analysis
  5.4.3 Segmental Analysis
  5.4.4 Research & Development
5.5 3M Healthcare
  5.5.1 Company Overview
  5.5.2 Financial Analysis
  5.5.3 Segmental Analysis
  5.5.4 Research & Development
5.6 GF Health Products, Inc
  5.6.1 Company Overview
5.7 Sunovion Pharmaceuticals Inc.
  5.7.1 Company Overview
5.8 Smith Medicals, Inc.
  5.8.1 Company Overview
  5.8.2 Financial Analysis
  5.8.3 Segmental Analysis
5.9 Baxter International
  5.9.1 Company Overview
  5.9.2 Financial Analysis
  5.9.3 Segmental Analysis
  5.9.4 Research & Development
5.1 Koninklijke Philips N.V.
  5.10.1 Company Overview
  5.10.2 Financial Analysis
  5.10.3 Segmental Analysis
  5.10.4 Research & Development

List Of Tables

LIST OF TABLES

TABLE 1 EUROPE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 2 EUROPE COPD AND ASTHMA DEVICES MARKET ($ MILLION): 2016-2022
TABLE 3 EUROPE COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 4 EUROPE COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 5 EUROPE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 6 EUROPE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 7 EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 8 EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 9 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 10 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 11 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2012-2015
TABLE 12 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2016-2022
TABLE 13 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2012-2015
TABLE 14 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2016-2022
TABLE 15 EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 16 EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 17 EUROPE COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 18 EUROPE COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 19 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 20 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 21 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2012-2015
TABLE 22 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2016-2022
TABLE 23 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2012-2015
TABLE 24 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2016-2022
TABLE 25 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 26 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 27 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 28 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 29 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 30 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 31 EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 32 EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 33
TABLE 34 EUROPE COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 35 EUROPE COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 36 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 37 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 38 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 39 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 40 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 41 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 42 EUROPE COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 43 EUROPE COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 44 RUSSIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 45 RUSSIA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 46 RUSSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 47 RUSSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 48 RUSSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 49 RUSSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 50 RUSSIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 51 RUSSIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 52 GERMANY COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 53 GERMANY COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 54 GERMANY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 55 GERMANY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 56 GERMANY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 57 GERMANY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 58 GERMANY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 59 GERMANY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 60 UK COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 61 UK COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 62 UK COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 63 UK COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 64 UK COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 65 UK COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 66 UK COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 67 UK COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 68 FRANCE COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 69 FRANCE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 70 NCE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 71 FRANCE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 72 FRANCE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 73 FRANCE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 74 FRANCE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 75 FRANCE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 76 SPAIN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 77 SPAIN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 78 SPAIN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 79 SPAIN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 80 SPAIN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 81 SPAIN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 82 SPAIN COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 83 SPAIN COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 84 ITALY COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 85 ITALY COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 86 ITALY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 87 ITALY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 88 ITALY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 89 ITALY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 90 ITALY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 91 ITALY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 92 REST OF EUROPE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 93 REST OF EUROPE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 94 REST OF EUROPE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 95 REST OF EUROPE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 96 REST OF EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 97 REST OF EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 98 REST OF EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 99 REST OF EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 100 KEY INFORMATION - GLAXOSMITHCLINE PLC.
TABLE 101 KEY INFORMATION - NOVARTIS INTERNATIONAL AG.
TABLE 102 KEY INFORMATION - BIOTRONIK SE & CO. KG.
TABLE 103 KEY INFORMATION - ASTRAZENECA PLC.
TABLE 104 KEY INFORMATION - 3M HEALTHCARE.
TABLE 105 KEY INFORMATION - GF HEALTH PRODUCTS, INC.
TABLE 106 KEY INFORMATION - SUNOVION PHARMACEUTICALS INC.
TABLE 107 KEY INFORMATION - SMITH MEDICALS, INC.
TABLE 108 KEY INFORMATION - BAXTER INTERNATIONAL.
TABLE 109 KONINKLIJKE PHILIPS N.V. COMPANY SNAPSHOT